La Jolla Pharmaceutical Company Profile (NASDAQ:LJPC)

About La Jolla Pharmaceutical

La Jolla Pharmaceutical logoLa Jolla Pharmaceutical Company is a biopharmaceutical company. The Company is focused on the discovery, development and commercialization of therapies to improve outcomes in patients suffering from life-threatening diseases. It is engaged in the research, development and commercialization of its technologies and drug candidates for pharmaceutical products. Its product candidates in development include LJPC-501, LJPC-401, LJPC-30Sa and LJPC-30Sb. The Company is developing LJPC-501 for the treatment of catecholamine-resistant hypotension (CRH). The Company is developing LJPC-401 for the treatment of iron overload, which occurs as a result of diseases, such as hereditary hemochromatosis, beta thalassemia, sickle cell disease and myelodysplastic syndrome. It is developing LJPC-30Sa and LJPC-30Sb not only for the treatment of serious bacterial infections but also for the potential treatment of rare genetic disorders, such as cystic fibrosis and Duchenne muscular dystrophy.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: LJPC
  • CUSIP:
Key Metrics:
  • Previous Close: $26.33
  • 50 Day Moving Average: $19.48
  • 200 Day Moving Average: $18.29
  • 52-Week Range: $18,254,000.00 - $12.68
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -7.02
  • P/E Growth: -0.55
  • Market Cap: $480.63M
  • Outstanding Shares: 18,254,000
  • Beta: 1.79
Profitability:
  • Net Margins: -3,520.34%
  • Return on Equity: -49.08%
  • Return on Assets: -44.46%
Debt:
  • Current Ratio: 19.83%
  • Quick Ratio: 19.83%
Additional Links:
Companies Related to La Jolla Pharmaceutical:

Analyst Ratings

Consensus Ratings for La Jolla Pharmaceutical (NASDAQ:LJPC) (?)
Ratings Breakdown: 6 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $42.40 (61.03% upside)
Analysts' Ratings History for La Jolla Pharmaceutical (NASDAQ:LJPC)
Show:
DateFirmActionRatingPrice TargetDetails
9/8/2016Chardan CapitalSet Price TargetBuy$80.00View Rating Details
9/8/2016Cowen and CompanySet Price TargetBuy$40.00View Rating Details
6/22/2016SunTrust Banks Inc.Initiated CoverageBuy$30.00View Rating Details
6/8/2016Jefferies GroupReiterated RatingBuyView Rating Details
5/24/2016Lake Street CapitalInitiated CoverageBuy$25.00View Rating Details
1/19/2016Noble FinancialReiterated RatingBuy$37.00View Rating Details
5/11/2015HC WainwrightLower Price TargetBuy$29.00 -> $20.00View Rating Details
4/20/2015Oppenheimer Holdings Inc.Initiated CoverageOutperform$43.00View Rating Details
(Data available from 9/25/2014 forward)

Earnings

Earnings History for La Jolla Pharmaceutical (NASDAQ:LJPC)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/4/2016        
8/8/2016Q2($0.99)($0.90)ViewN/AView Earnings Details
5/6/2016Q416($0.74)($0.96)ViewN/AView Earnings Details
11/6/2015Q315($0.71)($0.70)ViewN/AView Earnings Details
8/7/2015Q215($0.61)($0.70)ViewN/AView Earnings Details
3/16/2015Q414($0.37)($0.45)ViewN/AView Earnings Details
11/12/2014Q314($0.31)($0.37)ViewN/AView Earnings Details
8/14/2014Q214($0.69)($0.63)ViewN/AView Earnings Details
5/2/2014($0.91)($0.93)ViewN/AView Earnings Details
3/31/2014($0.24)($0.07)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for La Jolla Pharmaceutical (NASDAQ:LJPC)
Current Year EPS Consensus Estimate: $-3.72 EPS
Next Year EPS Consensus Estimate: $-3.75 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q2 20161($0.95)($0.95)($0.95)
Q3 20163($1.00)($0.97)($0.98)
Q4 20163($1.08)($0.77)($0.95)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for La Jolla Pharmaceutical (NASDAQ:LJPC)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for La Jolla Pharmaceutical (NASDAQ:LJPC)
Insider Ownership Percentage: 26.43%
Institutional Ownership Percentage: 87.52%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/13/2016Kevin C TangDirectorBuy139,035$19.82$2,755,673.70View SEC Filing  
3/4/2016Kevin C TangDirectorBuy20,000$19.85$397,000.00View SEC Filing  
3/1/2016George F TidmarshCEOBuy2,000$16.57$33,140.00View SEC Filing  
9/28/2015Lakhmir S ChawlaInsiderBuy485$27.75$13,458.75View SEC Filing  
9/10/2015Kevin C TangDirectorBuy80,000$38.00$3,040,000.00View SEC Filing  
8/21/2015Kevin C TangDirectorBuy170,000$27.11$4,608,700.00View SEC Filing  
6/26/2015Kevin C TangDirectorBuy110,000$23.58$2,593,800.00View SEC Filing  
6/24/2015Kevin C TangDirectorBuy220,000$22.23$4,890,600.00View SEC Filing  
6/23/2015Kevin C TangDirectorBuy53,836$22.27$1,198,927.72View SEC Filing  
6/22/2015Kevin C TangDirectorBuy77,850$21.41$1,666,768.50View SEC Filing  
5/13/2015Kevin C TangDirectorBuy190,583$18.24$3,476,233.92View SEC Filing  
5/12/2015George F TidmarshCEOBuy4,000$18.37$73,480.00View SEC Filing  
12/15/2014Kevin C TangDirectorBuy232,343$12.84$2,983,284.12View SEC Filing  
12/11/2014George F TidmarshCEOBuy4,000$11.38$45,520.00View SEC Filing  
9/26/2014George F TidmarshCEOBuy2,000$9.35$18,700.00View SEC Filing  
9/26/2014Kevin C TangDirectorBuy169,555$9.14$1,549,732.70View SEC Filing  
9/25/2014Kevin C TangDirectorBuy30,500$9.17$279,685.00View SEC Filing  
9/24/2014Kevin C TangDirectorBuy95,000$9.10$864,500.00View SEC Filing  
9/18/2014George F TidmarshCEOBuy5,000$9.18$45,900.00View SEC Filing  
7/23/2014George F TidmarshCEOBuy19,000$10.50$199,500.00View SEC Filing  
5/21/2014George TidmarshCEOBuy12,000$7.37$88,440.00View SEC Filing  
4/14/2014George TidmarshCEOBuy8,000$9.53$76,240.00View SEC Filing  
2/7/2014George F TidmarshCEOBuy3,000$7.25$21,750.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for La Jolla Pharmaceutical (NASDAQ:LJPC)
DateHeadline
News IconSell-side is Weighing in on La Jolla Pharmaceutical Company ... - Frisco Fastball (NASDAQ:LJPC)
friscofastball.com - September 25 at 5:19 PM
News IconLa Jolla Pharmaceutical Company (NASDAQ:LJPC) Is Up 20% In A Week After Our buy Alert (NASDAQ:LJPC)
www.marketnewscall.com - September 21 at 10:03 AM
News IconSell-side Consensus Sees La Jolla Pharmaceutical Company (NASDAQ:LJPC) Going Where Near-Term? - Frisco Fastball (NASDAQ:LJPC)
friscofastball.com - September 20 at 11:05 AM
investornewswire.com logoShares Of La Jolla Pharmaceutical Company (NASDAQ:LJPC) Expected To Hit $80 - Investor Newswire (NASDAQ:LJPC)
www.investornewswire.com - September 19 at 5:57 PM
4-traders.com logoLA JOLLA PHARMACEUTICAL CO : Other Events, Financial Statements and Exhibits (form 8-K) (NASDAQ:LJPC)
www.4-traders.com - September 19 at 10:29 AM
investornewswire.com logoCan La Jolla Pharmaceutical Company (NASDAQ:LJPC) Post EPS of $-0.91? - Investor Newswire (NASDAQ:LJPC)
www.investornewswire.com - September 16 at 5:45 PM
finance.yahoo.com logoLa Jolla Pharmaceutical (LJPC) Jumps: Stock Rises by 5.4% (NASDAQ:LJPC)
finance.yahoo.com - September 15 at 9:19 AM
seekingalpha.com logoInsiderInsights.com Daily Round Up 9/13/16: Monmouth Real Estate Investment Corp., La Jolla Pharmaceutical Co., Kadmon (NASDAQ:LJPC)
seekingalpha.com - September 14 at 6:01 PM
capitalcube.com logoLa Jolla Pharmaceutical Co. – Value Analysis (NASDAQ:LJPC) : September 12, 2016 (NASDAQ:LJPC)
www.capitalcube.com - September 12 at 5:42 PM
News IconStock Moving Up in Today's Session: La Jolla Pharmaceutical Co. (NASDAQ:LJPC) - Post News (NASDAQ:LJPC)
www.kentuckypostnews.com - September 10 at 10:18 AM
News IconShares Higher in Today's Session: La Jolla Pharmaceutical Co. (NASDAQ:LJPC) - Post News (NASDAQ:LJPC)
www.kentuckypostnews.com - September 8 at 5:47 PM
businesswire.com logoLa Jolla Pharmaceutical Company Announces Agreement with European Medicines Agency on Pivotal Study of LJPC ... - Business Wire (press release) (NASDAQ:LJPC)
www.businesswire.com - September 8 at 5:47 PM
thestreet.com logoShark Bites: Aratana Therapeutics Makes Its Move (NASDAQ:LJPC)
realmoney.thestreet.com - September 8 at 5:47 PM
rttnews.com logoCGNT Abuzz, Retrophin's DUET Hits Right Notes, Watch Out For RPRX (NASDAQ:LJPC)
www.rttnews.com - September 8 at 9:49 AM
streetinsider.com logoLa Jolla Pharmaceutical (LJPC) Announces Significant Data from LJPC-401 Phase 1 in Iron Overload (NASDAQ:LJPC)
www.streetinsider.com - September 8 at 9:49 AM
biz.yahoo.com logoLA JOLLA PHARMACEUTICAL CO Files SEC form 8-K, Other Events, Financial Statements and Exhibits (NASDAQ:LJPC)
biz.yahoo.com - September 8 at 9:49 AM
seekingalpha.com logoEuropean regulator OKs design of La Jolla Pharma's pivotal study of LJPC-401 in beta thalassemia, trial to start in mid-2017; shares up 4% after hours (NASDAQ:LJPC)
seekingalpha.com - September 7 at 6:05 PM
finance.yahoo.com logo4:17 pm La Jolla Pharm reports 'positive' results from its Phase 1 study of LJPC-401 in patients at risk of iron overload and announces agreement w/ the EMA on the design of a pivotal study of LJPC-401 (NASDAQ:LJPC)
finance.yahoo.com - September 7 at 6:05 PM
publicnow.com logoLa Jolla Pharmaceutical Company Reports Positive Results from Phase 1 Study of LJPC-401 (NASDAQ:LJPC)
www.publicnow.com - September 7 at 6:05 PM
publicnow.com logoLa Jolla Pharmaceutical Company Announces Agreement with European Medicines Agency on Pivotal Study of LJPC-401 (NASDAQ:LJPC)
www.publicnow.com - September 7 at 6:05 PM
investornewswire.com logoCan La Jolla Pharmaceutical Company (NASDAQ:LJPC) Keep Up With Analyst Expectations? - Investor Newswire (NASDAQ:LJPC)
www.investornewswire.com - September 5 at 10:15 AM
News IconStock Struggling for the Quarter: La Jolla Pharmaceutical Co. (NASDAQ:LJPC) - Post News (NASDAQ:LJPC)
www.kentuckypostnews.com - September 4 at 10:11 AM
capitalcube.com logoETF’s with exposure to La Jolla Pharmaceutical Co. : August 29, 2016 (NASDAQ:LJPC)
www.capitalcube.com - August 29 at 5:53 PM
capitalcube.com logoETF’s with exposure to La Jolla Pharmaceutical Co. : August 29, 2016 (NASDAQ:LJPC)
www.capitalcube.com - August 29 at 5:53 PM
4-traders.com logoLA JOLLA PHARMACEUTICAL CO : Change in Directors or Principal Officers, Submission of Matters to a Vote of Security Holders (form 8-K) (NASDAQ:LJPC)
www.4-traders.com - August 26 at 5:47 PM
biz.yahoo.com logoLA JOLLA PHARMACEUTICAL CO Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to a (NASDAQ:LJPC)
biz.yahoo.com - August 26 at 5:47 PM
capitalcube.com logoLa Jolla Pharmaceutical Co. breached its 50 day moving average in a Bearish Manner : LJPC-US : August 26, 2016 (NASDAQ:LJPC)
www.capitalcube.com - August 26 at 8:56 AM
investornewswire.com logoLa Jolla Pharmaceutical Company (NASDAQ:LJPC) Gets 0 Recommendations To Sell - Investor Newswire (NASDAQ:LJPC)
www.investornewswire.com - August 24 at 9:02 AM
News IconAnalysts & Crowd Weigh in on La Jolla Pharmaceutical Company (NASDAQ:LJPC) Stock - Post News (NASDAQ:LJPC)
www.kentuckypostnews.com - August 24 at 9:02 AM
News IconTSRI study supports new strategy to fight cocaine addiction (NASDAQ:LJPC)
www.sciencecodex.com - August 19 at 5:55 PM
News IconTSRI Scientists Find Potential Treatment for 'Painful Blindness' Form of Dry Eye (NASDAQ:LJPC)
sciencenewsline.com - August 19 at 5:55 PM
News IconLa Jolla (NASDAQ:LJPC)
www.onenewspage.com - August 18 at 9:00 AM
finance.yahoo.com logoLA JOLLA PHARMACEUTICAL CO Financials (NASDAQ:LJPC)
finance.yahoo.com - August 17 at 6:09 PM
kcregister.com logoShining on Major News: La Jolla Pharmaceutical Co. (NASDAQ:LJPC), Chimerix, Inc. (NASDAQ:CMRX), YY Inc ... - KC Register (NASDAQ:LJPC)
www.kcregister.com - August 16 at 9:16 AM
investornewswire.com logoWill La Jolla Pharmaceutical Company (NASDAQ:LJPC) Hit $80 Price Target? - Investor Newswire (NASDAQ:LJPC)
www.investornewswire.com - August 16 at 9:16 AM
biz.yahoo.com logoLA JOLLA PHARMACEUTICAL CO Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements an (NASDAQ:LJPC)
biz.yahoo.com - August 12 at 6:04 PM
finance.yahoo.com logoLa Jolla Pharmaceutical Company Announces Financial Results for the Three and Six Months Ended June 30, … (NASDAQ:LJPC)
finance.yahoo.com - August 9 at 6:09 PM
businesswire.com logoLa Jolla Pharmaceutical Company Announces Financial Results for ... - Business Wire (press release) (NASDAQ:LJPC)
www.businesswire.com - August 9 at 9:00 AM
publicnow.com logoLa Jolla Pharmaceutical Company Announces Financial Results for the Three and Six Months Ended June 30, 2016 (NASDAQ:LJPC)
www.publicnow.com - August 9 at 9:00 AM
sg.finance.yahoo.com logoLa Jolla Pharmaceutical posts 2Q loss (NASDAQ:LJPC)
sg.finance.yahoo.com - August 8 at 6:11 PM
investornewswire.com logoCan Shares Of La Jolla Pharmaceutical Company (NASDAQ:LJPC) Hit $80? - Investor Newswire (NASDAQ:LJPC)
www.investornewswire.com - July 26 at 9:00 AM
News IconLa Jolla Pharmaceutical Company Therapeutics and Product Pipeline Review H1 2016 (NASDAQ:LJPC)
www.medgadget.com - July 23 at 9:55 AM
4-traders.com logoLa Jolla Pharmaceutical Company : Therapeutics strategies and Product Pipeline Review 2016 (NASDAQ:LJPC)
www.4-traders.com - July 23 at 9:55 AM
News IconLa Jolla Pharmaceutical Company (NASDAQ:LJPC): Sell-Side Ratings and Company Earnings Glance - Engelwood Daily (NASDAQ:LJPC)
www.engelwooddaily.com - July 22 at 8:55 AM
News IconLa Jolla Pharmaceutical Company Can't Burn Your Long Portfolio. Has Another Strong Session - Consumer Eagle (NASDAQ:LJPC)
www.consumereagle.com - July 21 at 12:06 PM
News IconEarnings Focus and Crowd Sourced Sentiment Review for La Jolla Pharmaceutical Company (NASDAQ:LJPC) - TGP (NASDAQ:LJPC)
telanaganapress.com - July 20 at 4:05 PM
investornewswire.com logoIs $80 Price Target Attainable For La Jolla Pharmaceutical Company (NASDAQ:LJPC)? - Investor Newswire (NASDAQ:LJPC)
www.investornewswire.com - July 20 at 4:05 PM
News IconEquity Roundup: Stock Performance Focus on La Jolla Pharmaceutical Company (NASDAQ:LJPC) - Press Telegraph (NASDAQ:LJPC)
presstelegraph.com - July 20 at 4:05 PM
capitalcube.com logoLa Jolla Pharmaceutical Co. – Value Analysis (NASDAQ:LJPC) : July 18, 2016 (NASDAQ:LJPC)
www.capitalcube.com - July 18 at 3:57 PM
ftsenews.co.uk logoLa Jolla Pharmaceutical Company (LJPC) Updated Price Targets - FTSE News (NASDAQ:LJPC)
www.ftsenews.co.uk - July 18 at 11:14 AM

Social

La Jolla Pharmaceutical (NASDAQ:LJPC) Chart for Sunday, September, 25, 2016


Last Updated on 9/25/2016 by MarketBeat.com Staff